Unicycive Therapeutics Inc (UNCY)

Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	0.675	-	0.951
Operating Expenses	37.39% 5.938	4.322	4.877	5.325	6.505
Interest Income/Expense	43.75% 0.018	0.032	0.012	0.003	0.003
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	37.37% 5.937	4.322	4.877	5.325	6.505
Operating Income/Loss	37.39% -5.938	-4.322	-4.202	-5.325	-5.554
Income/Loss From Continuing Operations Before Tax	12.90% -4.333	-3.838	-14.57	-	0.951
Income/Loss From Continuing Operations After Tax	12.90% -4.333	-3.838	-14.57	-5.328	-5.557
Net Income/Loss	12.90% -4.333	-3.838	-14.57	-5.328	-5.557
Preferred Stock Dividends And Other Adjustments	88.06% 0.072	0.603	0.192	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	114.20% 32.63	15.23	15.23	0.00666	15.06
Diluted Average Shares	114.20% 32.63	15.23	15.23	0.00666	15.06
Basic Earnings Per Share	55.17% -0.13	-0.29	-0.97	-0.35	-0.37
Diluted Earnings Per Share	55.17% -0.13	-0.29	-0.97	-0.35	-0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.072	-	-	-	-